Guofeng Fu
Impact in
-
- Cancer Research and Treatments
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
-
- Metabolomics and Mass Spectrometry Studies 2
- Protein purification and stability 2
-
- Monoclonal and Polyclonal Antibodies Research 2
- Co-authors
- Guo Fu (6 shared papers)Xiao Lei Chen (5 shared papers)Bing Xu (3 shared papers)Li-Ying Feng (3 shared papers)Kai Chen (3 shared papers)Xian Jia (1 shared paper)Jian‐Dong Huang (1 shared paper)Xu Chen (1 shared paper)
- Journals
- Biomarker Research (2 papers)Ecotoxicology and Environmental Safety (1 paper)Cancer Letters (1 paper)Nature Communications (1 paper)Cell Death and Disease (1 paper)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Guofeng Fu
14 papers receiving 256 citations
Peers
Comparison fields: 5 of 69
- Biotechnology 36
- Immunology 73
- Hematology 29
- Oncology 61
- Molecular Biology 123
Countries citing papers authored by Guofeng Fu
This map shows the geographic impact of Guofeng Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guofeng Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guofeng Fu more than expected).
Fields of papers citing papers by Guofeng Fu
This network shows the impact of papers produced by Guofeng Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guofeng Fu. The network helps show where Guofeng Fu may publish in the future.
Co-authors
The 25 scholars most cited alongside Guofeng Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 74 | |
| 2 | 2019 | 47 | |
| 3 | 2020 | 25 | |
| 4 | 2018 | 25 | |
| 5 | 2019 | 20 | |
| 6 | 2020 | 18 | |
| 7 | 2019 | 14 | |
| 8 | 2017 | 13 | |
| 9 | 2016 | 8 | |
| 10 | 2015 | 6 | |
| 11 | 2024 | 3 | |
| 12 | 2022 | 3 | |
| 13 | 2022 | 2 | |
| 14 | 2015 | 1 |
About Guofeng Fu
Guofeng Fu is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Hematology, Spectroscopy and Immunology, having authored 14 papers that have together received 259 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (2 papers), Acute Myeloid Leukemia Research (2 papers), Metabolomics and Mass Spectrometry Studies (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Protein purification and stability (2 papers), Advanced Proteomics Techniques and Applications (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Smoking Behavior and Cessation (1 paper). The work is most often cited by research in Biotechnology (36 citations), Immunology (73 citations), Hematology (29 citations), Oncology (61 citations) and Molecular Biology (123 citations). Guofeng Fu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Guo Fu, Xiao Lei Chen, Bing Xu, Li-Ying Feng, Kai Chen, Xian Jia, Jian‐Dong Huang, Xu Chen, Shuhai Lin and Bao‐Zhong Zhang. Their work appears in journals such as Biomarker Research, Ecotoxicology and Environmental Safety, Cancer Letters, Nature Communications and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.